Biomimetic nitric oxide nanogenerators for synergistic gas-mild photothermal therapy of large solid tumor

The mild photothermal therapy of solid tumors was still bottlenecked by the uneven temperature distribution in tumor tissue and the autophagy-mediated resistance. Here, we leveraged the ultra-small size (approximately 0.32 nm) and autophagy inhibitory property of nitric oxide (NO) to overcome these limitations for enhanced gas-photothermal therapy of large tumors. An NO donor was loaded into mesoporous polydopamine and coated with tumor cell membranes for tumor-targeting delivery. The acid-triggered release of NO potently inhibited autophagy to block the pro-survival pathway of tumor cells. Besides, as a small-molecule gas, it diffused freely into deep regions and precisely eliminated the deep-seated tumor cells, resulting in approximately 90% tumor inhibition in the late-stage breast tumor model (>500 mm<sup>3</sup>). The NO gas therapy shows great potential for complementing other therapeutics for the synergistic therapy of large solid tumors.

Authors

Institutions

Publication Details

Journal
Acta Pharmaceutica Sinica B
Published
2025-11-16
DOI
https://doi.org/10.1016/j.apsb.2025.11.009
Primary Topic
Nanoplatforms for cancer theranostics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Biomimetic nitric oxide nanogenerators for synergistic gas-mild photothermal therapy of large solid tumor

Zhanwei Zhou, Minjie Sun, Honghao Sun, Ming Yan et al.
Acta Pharmaceutica Sinica B
Nanoplatforms for cancer theranostics
article

Biomimetic nitric oxide nanogenerators for synergistic gas-mild photothermal therapy of large solid tumor

Zhanwei Zhou, Minjie Sun, Honghao Sun, Ming Yan, Xinping Luo, Caixia Tan
article en

Abstract

The mild photothermal therapy of solid tumors was still bottlenecked by the uneven temperature distribution in tumor tissue and the autophagy-mediated resistance. Here, we leveraged the ultra-small size (approximately 0.32 nm) and autophagy inhibitory property of nitric oxide (NO) to overcome these limitations for enhanced gas-photothermal therapy of large tumors. An NO donor was loaded into mesoporous polydopamine and coated with tumor cell membranes for tumor-targeting delivery. The acid-triggered release of NO potently inhibited autophagy to block the pro-survival pathway of tumor cells. Besides, as a small-molecule gas, it diffused freely into deep regions and precisely eliminated the deep-seated tumor cells, resulting in approximately 90% tumor inhibition in the late-stage breast tumor model (>500 mm<sup>3</sup>). The NO gas therapy shows great potential for complementing other therapeutics for the synergistic therapy of large solid tumors.

Acta Pharmaceutica Sinica BVol. 16(2)
China Pharmaceutical University (CN)
Openalex Percentile: Top 66%
Nanoplatforms for cancer theranostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.